Filing Details

Accession Number:
0001140361-11-005894
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-02-03 13:30:46
Reporting Period:
2011-02-01
Filing Date:
2011-02-03
Accepted Time:
2011-02-03 13:30:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1048477 Biomarin Pharmaceutical Inc BMRN Pharmaceutical Preparations (2834) 680397820
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1401782 Mark Wood C/O Biomarin Pharmaceutical Inc.
105 Digital Drive
Novato CA 94949
Vp, Human Resources No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-02-01 84 $14.39 14,327 No 4 M Direct
Common Stock Acquisiton 2011-02-01 1,250 $17.33 15,577 No 4 M Direct
Common Stock Disposition 2011-02-01 1,334 $26.00 14,243 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2011-02-01 84 $0.00 84 $14.39
Common Stock Stock Option (right to buy) Disposition 2011-02-01 1,250 $0.00 1,250 $17.33
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
112,626 2009-11-12 2019-05-11 No 4 M Direct
111,376 2007-12-07 2017-06-06 No 4 M Direct
Footnotes
  1. Transaction made pursuant to a Rule 105-1 Trading plan executed on August 20, 2010.
  2. Original option grant vests 6/48th on November 1, 2009 and 1/48th each on the 12th of each month thereafter.
  3. Original option grant vests 6/48th on December 7, 2007 and 1/48th each on the 7th of each month thereafter.